Ignite Creation Date:
2024-05-06 @ 6:40 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05749042
Status:
RECRUITING
Last Update Posted:
2023-03-01
First Post:
2023-02-18
Brief Title:
A Study of Concurrent Chemoradiotherapy Based of Cisplatin With or Without Sintilimab as First-line Therapy for Patients With Advanced Oral Cavity Squamous Cell Carcinoma
Sponsor:
Xin-Hua Xu
Organization:
China Three Gorges University Yichang China
Organization Data
Organization:
China Three Gorges University Yichang China
Class:
OTHER
Study ID:
CTGU006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Xin-Hua Xu
Lead Sponsor Class:
OTHER
Responsible Party:
Xin-Hua Xu
Responsible Party Title:
professor
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
China Three Gorges University Yichang China
Old Name:
None
Old Organization:
None